Notice of Special Interest (NOSI): Competitive Revisions for Firearms Injury and Mortality Prevention Research
Notice Number: NOT-OD-20-089
Key Dates
Release Date: March 20, 2020
First Application Due Date: May 15, 2020
Expiration Date: May 16, 2020
Purpose
This Notice solicits competitive revision applications to support the expansion of existing R01 and R21 programs well poised to expand their focus to include firearms research as described below. Revision applications can support a significant expansion of the scope and research protocol approved and funded for the "parent" award on which the revision application is based. Prospective investigators can consult the contact list below to ensure that projects will contribute considerably to achieving the goal of this Notice.
Nearly 40,000 people in the U.S. die from firearm-related deaths each year, primarily from suicide (60%) or homicide (37%), and many more have experienced non-fatal firearm injuries, both intentional and nonintentional. The Joint Explanatory Statement accompanying the FY2020 Further Consolidated Appropriations Act (H.R. 1865) included funding for the NIH to conduct research on firearm injury and mortality prevention and recommended that NIH take a comprehensive approach to studying the underlying causes and evidence-based methods of prevention of firearm injury, including crime prevention. Within the legislative mandates and limitations of NIH funding (NOT-OD-20-068, NOT-OD-20-066), the NIH, via this NOSI, encourages research to improve understanding of the determinants of firearm injury, the identification of those at risk of firearm injury (including both victims and perpetrators), the development and evaluation of innovative interventions to prevent firearm injury and mortality, and the examination of approaches to improve the implementation of existing, evidence-based interventions to prevent firearm injury and mortality.
Application and Submission Information
Applicants do not need to apply to the same FOA that the parent grant was submitted to. Instead, we will be using existing FOAs noted below for application submission. In an exception to standard practice, the participating institutes/centers will accept competitive revision applications submitted to the FOAs listed below. Receipt dates indicated in these FOAs do not apply to applications responding to this request for competitive revisions. Therefore, applicants must submit competitive revision applications by April X, 2020 as described below by 5pm at the local time of the applicant organization.
Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcement through the expiration date of this notice.
For applicants with a current active R01:
- PA-19-055 - NIH Research Project Grant (Parent R01 Clinical Trial Required)
- PA-19-056 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- PA-19-091 – NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
For applicants with a current active R21: - PA-19-053, NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- PA-19-054, NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
- PA-19-092, NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required)
All instructions in the SF424 (R&R) Application Guide and the funding opportunity announcement used for submission must be followed, with the following additions: - Resource Sharing Plans are expected to must include a data sharing plan that describes their proposed process for making resulting publications, code, and to the extent possible, the underlying primary data immediately and broadly available to the public. See Section 8.2.3.1 of the NIH GPS.
The NIH Policy on Dissemination of NIH-funded Clinical Trial Information establishes the expectation that all NIH-funded recipients and investigators conducting clinical trials, funded in whole or in part by the NIH, will ensure that their clinical trials are registered at, and that summary results information is submitted to, ClinicalTrials.gov for public posting. See Section 4.1.3 of the NIH GPS.
Applicants will be expected to submit plans for pre-registration of research projects using publicly available platforms or ClinicalTrials.gov as applicable. Funded awardees that are not using ClinicalTrials.gov should provide in their annual progress reports the unique identifier assigned by the alternative platform, if available, and a link to the report (e.g., page or record) in the alternative platform.
NIH Public Access Policy
NIH-funded investigators are required by Federal law to submit (or have submitted for them) to the NIH National Library of Medicine PubMed Central an electronic version of the final, peer-reviewed manuscript upon acceptance for publication, to be made publicly available no later than 12 months after the official date of publication. See Section 8.2.2 of the NIH GPS.
One-year supplement applications may be submitted with budgets up to $200,000 in direct costs. The project and budget periods must be within the currently approved project period for the existing parent award and the parent grant must be active when the application is submitted. Projects currently in a no-cost extension status are not eligible to apply.
For funding consideration, applicants must include "NOT-OD-20-089" (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.
Applications nonresponsive to terms of this NOSI will be withdrawn from consideration for this initiative.
Standard review criteria used in the FOAs noted above apply.
Inquiries
Please direct all inquiries to the contacts in Section VII of the listed funding opportunity announcements with the following additions/substitutions to:
Dara Blachman-Demner, Ph.D.
Office of Behavioral and Social Sciences Research
National Institutes of Health
Telephone: 301-496-8522
Email: dara.blachman-demner@nih.gov
| 
No comments:
Post a Comment